TipRanks
Simcere Pharmaceutical Group Limited (HK:2096)
:2096
Hong Kong Market
2096
Simcere Pharmaceutical Group Limited
RESEARCH TOOLSreports
Want to see HK:2096 full AI Analyst Report?

Simcere Pharmaceutical Group Limited (2096) Ratios

4 Followers

Simcere Pharmaceutical Group Limited Ratios

HK:2096's free cash flow for Q2 2026 was ¥0.83. For the 2026 fiscal year, HK:2096's free cash flow was decreased by ¥ and operating cash flow was ¥0.21. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.90 2.21 2.00 2.10 1.84
Quick Ratio
 1.74 2.03 1.79 1.81 1.74
Cash Ratio
 0.79 1.06 0.71 0.75 0.56
Solvency Ratio
 0.33 0.32 0.21 0.28 0.31
Operating Cash Flow Ratio
 0.71 0.60 0.51 0.06 0.46
Short-Term Operating Cash Flow Coverage
 2.42 1.91 1.32 0.15 1.05
Net Current Asset Value
¥ 1.49B¥ 2.08B¥ 1.02B¥ 2.01B¥ 1.82B
Leverage Ratios
Debt-to-Assets Ratio
 0.16 0.08 0.11 0.13 0.14
Debt-to-Equity Ratio
 0.26 0.13 0.17 0.20 0.21
Debt-to-Capital Ratio
 0.21 0.11 0.15 0.17 0.17
Long-Term Debt-to-Capital Ratio
 0.12 <0.01 <0.01 0.03 0.00
Financial Leverage Ratio
 1.64 1.57 1.63 1.50 1.51
Debt Service Coverage Ratio
 1.45 1.42 1.13 1.01 0.65
Interest Coverage Ratio
 19.09 16.24 12.19 20.59 25.07
Debt to Market Cap
 0.10 0.04 0.06 0.08 0.05
Interest Debt Per Share
 0.99 0.52 0.51 0.55 0.59
Net Debt to EBITDA
 -0.32 -1.31 -0.54 -0.53 -0.19
Profitability Margins
Gross Profit Margin
82.86%81.61%80.25%75.43%79.08%
EBIT Margin
18.99%18.33%17.12%11.72%9.60%
EBITDA Margin
23.77%23.26%20.35%16.41%12.90%
Operating Profit Margin
20.94%20.12%12.78%10.77%13.65%
Pretax Profit Margin
20.84%19.59%12.36%11.20%14.06%
Net Profit Margin
17.98%17.38%11.05%10.82%14.73%
Continuous Operations Profit Margin
17.96%17.38%11.05%10.80%14.67%
Net Income Per EBT
86.29%88.75%89.42%96.58%104.81%
EBT Per EBIT
99.53%97.35%96.68%103.97%102.97%
Return on Assets (ROA)
10.08%9.12%6.37%6.59%8.63%
Return on Equity (ROE)
16.54%14.28%10.37%9.90%13.06%
Return on Capital Employed (ROCE)
15.73%13.66%9.66%8.71%11.03%
Return on Invested Capital (ROIC)
12.32%11.05%7.66%7.41%9.41%
Return on Tangible Assets
11.26%10.22%7.09%7.15%9.10%
Earnings Yield
6.57%5.02%4.35%4.54%3.47%
Efficiency Ratios
Receivables Turnover
 3.43 2.61 2.45 2.50 2.52
Payables Turnover
 7.67 5.91 4.75 5.12 3.94
Inventory Turnover
 2.35 2.41 2.21 2.11 4.34
Fixed Asset Turnover
 3.16 3.05 2.92 3.04 2.91
Asset Turnover
 0.56 0.52 0.58 0.61 0.59
Working Capital Turnover Ratio
 2.28 2.28 2.33 2.43 2.87
Cash Conversion Cycle
 214.35 229.58 237.62 247.90 136.21
Days of Sales Outstanding
 106.43 139.94 149.08 146.08 144.67
Days of Inventory Outstanding
 155.53 151.42 165.33 173.13 84.13
Days of Payables Outstanding
 47.61 61.78 76.79 71.31 92.59
Operating Cycle
 261.96 291.36 314.41 319.21 228.81
Cash Flow Ratios
Operating Cash Flow Per Share
 1.09 0.81 0.55 0.06 0.52
Free Cash Flow Per Share
 0.86 0.46 0.25 -0.31 0.26
CapEx Per Share
 0.23 0.35 0.30 0.37 0.26
Free Cash Flow to Operating Cash Flow
 0.79 0.57 0.45 -5.49 0.50
Dividend Paid and CapEx Coverage Ratio
 2.84 1.61 1.20 0.11 1.27
Capital Expenditure Coverage Ratio
 4.67 2.34 1.82 0.15 2.00
Operating Cash Flow Coverage Ratio
 1.14 1.68 1.15 0.11 0.90
Operating Cash Flow to Sales Ratio
 0.32 0.26 0.21 0.02 0.21
Free Cash Flow Yield
9.18%4.30%3.73%-5.27%2.53%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 15.23 19.91 22.99 22.01 28.78
Price-to-Sales (P/S) Ratio
 2.75 3.46 2.54 2.38 4.24
Price-to-Book (P/B) Ratio
 2.52 2.84 2.39 2.18 3.76
Price-to-Free Cash Flow (P/FCF) Ratio
 10.90 23.24 26.82 -18.99 39.59
Price-to-Operating Cash Flow Ratio
 8.51 13.29 12.12 104.18 19.78
Price-to-Earnings Growth (PEG) Ratio
 0.21 0.23 3.10 -0.88 -0.76
Enterprise Value Multiple
 11.26 13.57 11.94 13.98 32.67
Enterprise Value
 23.20B 24.40B 16.12B 15.16B 26.64B
EV to EBITDA
 11.26 13.57 11.94 13.98 32.67
EV to Sales
 2.68 3.16 2.43 2.29 4.22
EV to Free Cash Flow
 10.60 21.19 25.65 -18.29 39.37
EV to Operating Cash Flow
 8.33 12.12 11.59 100.35 19.67
Tangible Book Value Per Share
 3.08 3.15 2.33 2.40 2.52
Shareholders’ Equity Per Share
 3.69 3.78 2.80 2.73 2.73
Tax and Other Ratios
Effective Tax Rate
 0.14 0.11 0.11 0.04 -0.05
Revenue Per Share
 3.40 3.11 2.62 2.50 2.42
Net Income Per Share
 0.61 0.54 0.29 0.27 0.36
Tax Burden
 0.86 0.89 0.89 0.97 1.05
Interest Burden
 1.10 1.07 0.72 0.96 1.46
Research & Development to Revenue
 0.11 0.20 0.21 0.24 0.27
SG&A to Revenue
 0.45 0.45 0.46 0.07 0.07
Stock-Based Compensation to Revenue
 0.00 0.01 0.01 <0.01 0.02
Income Quality
 1.79 1.33 1.70 0.20 1.53
Currency in CNY